กาแฟและสุขภาพตับ
บทคัดย่อ
No available
References
Pintus F, Mascia P. Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. ùATSSARDEGNAû
Research Group. Eur J Epidemiol 1996;12:71-6.
Nilssen O, Førde OH, Brenn T. The Tromsø Study. Distribution and population determinants of gammaglutamyltransferase. Am J Epidemiol 1990;132:318-26.
Nilssen O, Førde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study. Am J Epidemiol 1994;139:787-92.
Skurtveit S, Tverdal A. Sex differences in gammaglutamyltransferase in people aged 40-42 years in two Norwegian counties. Drug Alcohol Depend 2002;67:95-8.
Nakanishi N, Nakamura K, Nakajima K, Suzuki K,Tatara K. Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-aged Japanese men. Eur J Epidemiol 2000;16:419-23.
Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, et al. Coffee consumption and decreased serum gamma-glutamyltransferase and
aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998;27:438-43.
Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J
Clin Epidemiol 2001;54:823-9.
Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 1993;9:293-7.
Ikeda M, Maki T, Yin G, Kawate H, Adachi M, Ohnaka K, et al. Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index. Scand J Clin Lab Invest 2010;70:171-9.
Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol 1993;3:375-81.
Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005;129:1928-36.
Liu F, Wang X, Wu G, Chen L, Hu P, Ren H, et al. Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis. PLoS One 2015;10:e0142457.
Zelber-Sagi S, Salomone F, Webb M, Lotan R, Yeshua H, Halpern Z, et al. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Transl Res 2015;165:428-36.
Shen H, Rodriguez AC, Shiani A, Lipka S, Shahzad G, Kumar A, et al. Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic
review and meta-analysis. Therapeutic Advances in Gastroenterology 2016;9:113-20.
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and
endemicity. Vaccine 2012;30:2212-9.
Ong A, Wong VW, Wong GL, Chan HL. The effect of caffeine and alcohol consumption on liver fibrosis - a study of 1045 Asian hepatitis B patients using transient elastography. Liver Int 2011;31:1047-53.
Cardin R, Piciocchi M, Martines D, Scribano L, Petracco M, Farinati F. Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial.
Dig Liver Dis 2013;45:499-504.
Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, et al. Coffee intake is associated with lower rates of liver disease progression
in chronic hepatitis C. Hepatology 2009;50:1360-9.
Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol
;11:1413-21.e1.
Bravi F, Tavani A, Bosetti C, Boffetta P, La Vecchia C. Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and
meta-analysis of prospective studies. Eur J Cancer Prev 2016 Apr 22. [Epub ahead of print]
Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012;
:1891-904.
Ding M1, Satija A, Bhupathiraju SN1, Hu Y1, Sun Q1, Han J, et al. Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts. Circulation 2015;132:2305-15.
Saab S, Mallam D, Cox GA 2nd, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int 2014;34:495-504.
Ng V, Saab S. Can daily coffee consumption reduce liver disease-related mortality? Clin Gastroenterol Hepatol 2013;11:1422-3.
Wadhawan M, Anand AC. Coffee and Liver Disease. J Clin Exp Hepatol 2016;6:40-6.
Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, Vartiainen E, et al. Joint effects of coffee consumption and serum gamma-glutamyltransferase
on the risk of liver cancer. Hepatology 2008; 48:129-36.
Hasin DS, OûBrien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale.
Am J Psychiatry 2013;170:834-51.
Anty R, Marjoux S, Iannelli A, Patouraux S, Schneck AS, Bonnafous S, et al. Regular coffee but not espresso drinking is protective against fibrosis in a cohort
mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 2012;57:1090-6.
Downloads
เผยแพร่แล้ว
How to Cite
ฉบับ
บท
License
เนื้อหาและข้อมูลในบทความที่ตีพิมพ์ลงใน Thai JPEN วารสารโภชนบำบัด ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสารไม่จำเป็นต้องเห็นด้วยหรือร่วมรับผิดชอบใด ๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ใน Thai JPEN วารสารโภชนบำบัด ถือเป็นลิขสิทธิ์ของ Thai JPEN วารสารโภชนบำบัด หากบุคคลหรืหน่วยงานใดต้องการนำทั้งหมดหรือส่วนใดส่วนหนึ่งไปเผยแพร่หรือเพื่อกระทำการใด จะต้องได้รับอนุญาตเป็นลายลักษณ์อักษรจาก Thai JPEN วารสารโภชนบำบัด ก่อนเท่านั้น
